Abstract
IntroductionHereditary causes of visceral thrombosis or thrombosis should be sought among young patients. We present a case of a young man presenting with multiple hepatic infarctions resulting in portal hypertension due to homozygosity of the prothrombin gene mutation not previously described in literature.Case presentationA 42-year-old Caucasian man with a previous history of idiopathic deep vein thrombosis 11 years earlier presented with vague abdominal pains and mildly abnormal liver function tests. An ultrasound and computed tomography scan showed evidence of hepatic infarction and portal hypertension (splenic varices). A thrombophilia screen confirmed a homozygous mutation for the prothrombin gene mutation, with mildly reduced levels of anti-thrombin III (AT III). Subsequent testing of his father and brother revealed heterozygosity for the same gene mutation.ConclusionHepatic infarction is unusual due to the rich dual arterial and venous blood supply to the liver. In the absence of an arterial or haemodynamic insult causing hepatic infarction, a thrombophilia should be considered. To our knowledge, this is the first reported case of a hepatic infarction due to homozygosity of the prothrombin gene mutation. It is unclear whether homozygotes have a higher risk of thrombosis than heterozygotes. In someone presenting with a first thrombosis with this mutation, the case for life-long anticoagulation is unclear, but it may be necessary to prevent a second and more severe second thrombotic event, as occurred in this case.
Highlights
Hereditary causes of visceral thrombosis or thrombosis should be sought among young patients
In the absence of an arterial or haemodynamic insult causing hepatic infarction, a thrombophilia should be considered. This is the first reported case of a hepatic infarction due to homozygosity of the prothrombin gene mutation. It is unclear whether homozygotes have a higher risk of thrombosis than heterozygotes
In someone presenting with a first thrombosis with this mutation, the case for life-long anticoagulation is unclear, but it may be necessary to prevent a second and more severe second thrombotic event, as occurred in this case
Summary
Individuals who are heterozygotes for multiple prothrombotic mutations are prone to thromboses. The four-year risk of recurrent DVT for 20210A heterozygotes is no greater than that for non-thrombophilic DVT patients [15,16]; but a 10-year follow-up study showed the risk to be increased 2.4 fold [17]. There is at present insufficient evidence pointing to a need for life-long anticoagulation of heterozygous carriers of the prothrombin gene mutation after a single episode of DVT. In this case, there was limb DVT and a visceral thrombosis with secondary portal hypertension justifying life-long anticoagulation. Consent Written informed consent was obtained from the patient for publication of this case report and accompanying images.
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have